Tags

Type your tag names separated by a space and hit enter

[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Sangre (Barc). 1998 Jun; 43(3):179-84.S

Abstract

BACKGROUND

Retrospective analysis of 70 patients with Hodgkin's disease (HD) and treated consecutively in our center between 1979 and 1993.

PATIENTS AND METHODS

All ganglionar biopsies were reviewed and finally 60 patients were selected: 43 males and 17 females with a median age of 39 years (12-79) and the following features: 55% III-IV stages, 25% extranodal involvement, 32% bulky mediastinum and 57% B-symptoms. Scheme of treatment: Only radiotherapy in 9 patients with localized stages and no adverse factors; only chemotherapy in 25 with advanced stages and combined therapy in 15 with localized stages and any adverse factor and in 7 with advanced stage and bulky disease. Chemotherapy was mainly based on MOPP until 1987 and MOPP/ABVD afterwards. Only four patients did not follow this scheme: 2 due to progression, 1 due to toxicity and 1 due to medical decision.

RESULTS

Fifty patients achieved complete remission (CR), 2 partial and 8 minimal response or progression under therapy. Eleven patients have died: 6 due to HD, 4 of second neoplasias and 1 of an opportunistic infection. With a median follow-up for surviving patients of 4.8 years (1-2), the estimated overall survival at 8 years is 67.7% (SD 9%), tumor mortality 82.6% (SD 7%) and progression free survival 66.7% (SD 7%). Disease free survival for CR patients is 78.4% (SD 9%). Response to treatment was the only factor significantly associated with survival (p = 0.0001). The estimated survival for CR patients who relapsed is 92.3% versus 28% for those who did not obtain a CR (p = 0.0001).

CONCLUSION

In our experience, first line therapy adjusted to clinical features at diagnosis has good results. Response to treatment has been the determinant factor for survival, mostly because salvage treatments, including high-dose chemotherapy approaches, have been of little effectiveness.

Authors+Show Affiliations

Servicio de Hematología, Hospital Universitario de la Princesa, Madrid.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

spa

PubMed ID

9741222

Citation

Arranz, R, et al. "[Outcome of 70 Patients Diagnosed With Hodgkin's Disease After First-line and Salvage Treatment: Experience at One Center]." Sangre, vol. 43, no. 3, 1998, pp. 179-84.
Arranz R, Gil-Fernández JJ, Muñoz E, et al. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. Sangre (Barc). 1998;43(3):179-84.
Arranz, R., Gil-Fernández, J. J., Muñoz, E., Acevedo, A., Sobrino, M. P., & Fernández-Rañada, J. M. (1998). [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. Sangre, 43(3), 179-84.
Arranz R, et al. [Outcome of 70 Patients Diagnosed With Hodgkin's Disease After First-line and Salvage Treatment: Experience at One Center]. Sangre (Barc). 1998;43(3):179-84. PubMed PMID: 9741222.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. AU - Arranz,R, AU - Gil-Fernández,J J, AU - Muñoz,E, AU - Acevedo,A, AU - Sobrino,M P, AU - Fernández-Rañada,J M, PY - 1998/9/19/pubmed PY - 1998/9/19/medline PY - 1998/9/19/entrez SP - 179 EP - 84 JF - Sangre JO - Sangre (Barc) VL - 43 IS - 3 N2 - BACKGROUND: Retrospective analysis of 70 patients with Hodgkin's disease (HD) and treated consecutively in our center between 1979 and 1993. PATIENTS AND METHODS: All ganglionar biopsies were reviewed and finally 60 patients were selected: 43 males and 17 females with a median age of 39 years (12-79) and the following features: 55% III-IV stages, 25% extranodal involvement, 32% bulky mediastinum and 57% B-symptoms. Scheme of treatment: Only radiotherapy in 9 patients with localized stages and no adverse factors; only chemotherapy in 25 with advanced stages and combined therapy in 15 with localized stages and any adverse factor and in 7 with advanced stage and bulky disease. Chemotherapy was mainly based on MOPP until 1987 and MOPP/ABVD afterwards. Only four patients did not follow this scheme: 2 due to progression, 1 due to toxicity and 1 due to medical decision. RESULTS: Fifty patients achieved complete remission (CR), 2 partial and 8 minimal response or progression under therapy. Eleven patients have died: 6 due to HD, 4 of second neoplasias and 1 of an opportunistic infection. With a median follow-up for surviving patients of 4.8 years (1-2), the estimated overall survival at 8 years is 67.7% (SD 9%), tumor mortality 82.6% (SD 7%) and progression free survival 66.7% (SD 7%). Disease free survival for CR patients is 78.4% (SD 9%). Response to treatment was the only factor significantly associated with survival (p = 0.0001). The estimated survival for CR patients who relapsed is 92.3% versus 28% for those who did not obtain a CR (p = 0.0001). CONCLUSION: In our experience, first line therapy adjusted to clinical features at diagnosis has good results. Response to treatment has been the determinant factor for survival, mostly because salvage treatments, including high-dose chemotherapy approaches, have been of little effectiveness. SN - 0036-4355 UR - https://www.unboundmedicine.com/medline/citation/9741222/[Outcome_of_70_patients_diagnosed_with_Hodgkin's_disease_after_first_line_and_salvage_treatment:_experience_at_one_center]_ L2 - https://medlineplus.gov/hodgkindisease.html DB - PRIME DP - Unbound Medicine ER -